BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19786161)

  • 1. Side effects of phytoestrogens: a meta-analysis of randomized trials.
    Tempfer CB; Froese G; Heinze G; Bentz EK; Hefler LA; Huber JC
    Am J Med; 2009 Oct; 122(10):939-46.e9. PubMed ID: 19786161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial response to raloxifene compared with placebo, cyclical hormone replacement therapy, and unopposed estrogen in postmenopausal women.
    Davies GC; Huster WJ; Shen W; Mitlak B; Plouffe L; Shah A; Cohen FJ
    Menopause; 1999; 6(3):188-95. PubMed ID: 10486787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.
    Zhang G; Qin L; Shi Y
    J Bone Miner Res; 2007 Jul; 22(7):1072-9. PubMed ID: 17419678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium.
    Balk JL; Whiteside DA; Naus G; DeFerrari E; Roberts JM
    J Soc Gynecol Investig; 2002; 9(4):238-42. PubMed ID: 12113884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
    Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytoestrogens and endometrial hyperplasia.
    Prescrire Int; 2006 Apr; 15(82):62-3. PubMed ID: 16607696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer and hormonal therapy.
    Conner P; Lundström E; von Schoultz B
    Clin Obstet Gynecol; 2008 Sep; 51(3):592-606. PubMed ID: 18677153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of phytoestrogen intake for breast cancer.
    Duffy C; Perez K; Partridge A
    CA Cancer J Clin; 2007; 57(5):260-77. PubMed ID: 17855484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of phytoestrogen therapy on the endometrium in postmenopausal women].
    Caserta L; Caserta R; Torella M; Nappo C; De Lucia D; Panariello S
    Minerva Ginecol; 2005 Oct; 57(5):551-5. PubMed ID: 16205600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapy.
    Hedblad B; Merlo J; Manjer J; Engström G; Berglund G; Janzon L
    Scand J Public Health; 2002; 30(1):12-9. PubMed ID: 11928828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
    Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.
    Steiner AZ; Xiang M; Mack WJ; Shoupe D; Felix JC; Lobo RA; Hodis HN
    Obstet Gynecol; 2007 Mar; 109(3):581-7. PubMed ID: 17329508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.
    Casella G; Ottani F; Pavesi PC; Sangiorgio P; Rubboli A; Galvani M; Fontanelli A; Bracchetti D
    Ital Heart J; 2003 Oct; 4(10):677-84. PubMed ID: 14664280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.